ZIVO Bioscience, Inc.
OTC: ZIVO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- John Bernard Payne
- Employees
- 7
- Headquarters
- Bloomfield Hills, United States
- IPO year
- 2003
- Market cap
- $12.3M
- Website
- https://www.zivobioscience.com
Loading ZIVO…
Loading profile data…Frequently asked questions about ZIVO
What does ZIVO Bioscience, Inc. (ZIVO) do?
ZIVO Bioscience, Inc. is a research and development firm that specializes in the creation and commercialization of natural bioactive compounds. These unique ingredients, derived from its proprietary algae cultures, are licensed and sold to manufacturers producing goods for animal health, human consumption, dietary supplements, and medical foods....
Where does ZIVO trade?
ZIVO Bioscience, Inc. (ZIVO) trades on the Other OTC.
What sector is ZIVO in?
ZIVO Bioscience, Inc. (ZIVO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of ZIVO Bioscience, Inc.?
John Bernard Payne is the chief executive officer of ZIVO Bioscience, Inc. (ZIVO).
Where is ZIVO Bioscience, Inc. headquartered?
ZIVO Bioscience, Inc. is headquartered in United States.
Does ZIVO pay a dividend?
ZIVO Bioscience, Inc. (ZIVO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ZIVO go public?
ZIVO Bioscience, Inc. (ZIVO) completed its initial public offering in 2003.